![Report Australia - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/australia-hormones-prostaglandins-thromboxanes-and-leukotrienes-market-analysis-forecast-size-trends-and-insights.webp)
Australia - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingAustralia: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Australia
For the fourth consecutive year, the Australian market for hormones, prostaglandins, thromboxanes and leukotrienes recorded decline in sales value, which decreased by X% to $X in 2023. Overall, consumption, however, continues to indicate noticeable growth. As a result, consumption attained the peak level of $X. From 2020 to 2023, the growth of the market failed to regain momentum.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Australia
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production dropped to $X in 2023 estimated in export price. Over the period under review, production, however, saw a significant increase. The growth pace was the most rapid in 2016 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2019; however, from 2020 to 2023, production stood at a somewhat lower figure.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from Australia
In 2023, shipments abroad of hormones, prostaglandins, thromboxanes and leukotrienes decreased by X% to X tons for the first time since 2020, thus ending a two-year rising trend. In general, exports saw a noticeable contraction. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. As a result, the exports attained the peak of X tons. From 2019 to 2023, the growth of the exports remained at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports reduced to $X in 2023. Overall, exports, however, continue to indicate a buoyant increase. The pace of growth appeared the most rapid in 2018 with an increase of X%. As a result, the exports attained the peak of $X. From 2019 to 2023, the growth of the exports remained at a lower figure.
Exports by Country
The UK (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from Australia, with a X% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to the UK exceeded the volume sent to the second major destination, Malaysia (X kg), more than tenfold. The third position in this ranking was held by New Zealand (X kg), with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of volume to the UK totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Malaysia (X% per year) and New Zealand (X% per year).
In value terms, the UK ($X) remains the key foreign market for hormones, prostaglandins, thromboxanes and leukotrienes exports from Australia, comprising X% of total exports. The second position in the ranking was taken by the United States ($X), with a X% share of total exports. It was followed by Malaysia, with a X% share.
From 2012 to 2023, the average annual growth rate of value to the UK stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Malaysia (X% per year).
Export Prices by Country
The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per ton in 2023, therefore, remained relatively stable against the previous year. Overall, the export price saw a prominent expansion. The most prominent rate of growth was recorded in 2019 an increase of X%. The export price peaked at $X,173 per ton in 2020; however, from 2021 to 2023, the export prices stood at a somewhat lower figure.
There were significant differences in the average prices for the major foreign markets. In 2023, amid the top suppliers, the country with the highest price was Belgium ($X,000 per ton), while the average price for exports to Malaysia ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Belgium (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into Australia
In 2023, overseas purchases of hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to X tons, rising for the second year in a row after two years of decline. Overall, imports, however, recorded a abrupt decrease. The most prominent rate of growth was recorded in 2019 with an increase of X%. As a result, imports reached the peak of X tons. From 2020 to 2023, the growth of imports remained at a lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports contracted notably to $X in 2023. Over the period under review, imports, however, recorded a abrupt curtailment. The growth pace was the most rapid in 2016 when imports increased by X% against the previous year. Imports peaked at $X in 2019; however, from 2020 to 2023, imports failed to regain momentum.
Imports by Country
China (X tons), France (X tons) and the United States (X tons) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to Australia, with a combined X% share of total imports.
From 2012 to 2023, the biggest increases were recorded for France (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, France ($X) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to Australia, comprising X% of total imports. The second position in the ranking was taken by China ($X), with a X% share of total imports. It was followed by the United States, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value from France stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: China (X% per year) and the United States (X% per year).
Import Prices by Country
In 2023, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, which is down by X% against the previous year. In general, the import price, however, recorded a notable increase. The pace of growth appeared the most rapid in 2017 when the average import price increased by X% against the previous year. Over the period under review, average import prices reached the peak figure at $X per kg in 2018; however, from 2019 to 2023, import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the UK ($X per kg), while the price for New Zealand ($X per kg) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by France (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Australia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- Australia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Australia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
- Market Research in Australia
- Price for Hormones, Prostaglandins, Thromboxanes and Leukotrienes Australia
- Hormones Market
- Sterile Medical Adhesion Barrier Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Veterinary Medicine Vaccines Market